This is the second part of my investigative report. If you valued reading Part 1, consider becoming a paid subscriber or make a one-off contribution.
I turned to the lead author of the Speicher et al. paper, David Speicher Ph.D., molecular virologist and writer of
for his view on the UK’s MHRA recent disclosure of …Keep reading with a 7-day free trial
Subscribe to Sonia Elijah investigates to keep reading this post and get 7 days of free access to the full post archives.